Semaglutide's Success Could Usher in a "New Dawn" for Obesity Treatment

JAMA. 2021 Jul 13;326(2):121-123. doi: 10.1001/jama.2021.10307.
No abstract available

Publication types

  • News

MeSH terms

  • Anti-Obesity Agents / therapeutic use*
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Glucagon-Like Peptides / therapeutic use*
  • Humans
  • Obesity / drug therapy*

Substances

  • Anti-Obesity Agents
  • Glucagon-Like Peptide-1 Receptor
  • semaglutide
  • Glucagon-Like Peptides